Mobia Medical, Inc. (NASDAQ:MOBI – Get Free Report) saw a large decline in short interest in July. As of July 15th, there was short interest totaling 422,393 shares, a decline of 65.8% from the June 30th total of 1,234,096 shares. Approximately 1.3% of the company’s shares are short sold. Based on an average trading volume of 123,091 shares, the days-to-cover ratio is presently 3.4 days.
Analysts Set New Price Targets
A number of analysts recently commented on MOBI shares. Wall Street Zen raised Mobia Medical from a “sell” rating to a “hold” rating in a research report on Sunday, June 14th. The Goldman Sachs Group assumed coverage on Mobia Medical in a report on Tuesday, June 2nd. They set a “buy” rating and a $31.00 price objective for the company. Bank of America initiated coverage on Mobia Medical in a research report on Tuesday, June 2nd. They set a “buy” rating and a $16.00 target price on the stock. BTIG Research began coverage on Mobia Medical in a report on Tuesday, June 2nd. They issued a “buy” rating and a $19.00 target price on the stock. Finally, Wolfe Research assumed coverage on shares of Mobia Medical in a research report on Tuesday, June 2nd. They issued an “outperform” rating for the company. Five investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $20.25.
Read Our Latest Report on MOBI
Mobia Medical Price Performance
Mobia Medical (NASDAQ:MOBI – Get Free Report) last posted its earnings results on Thursday, June 4th. The company reported ($19.30) earnings per share for the quarter. The firm had revenue of $12.07 million during the quarter.
Insider Buying and Selling
In related news, major shareholder Osage University Gp Iii, Llc purchased 533,333 shares of Mobia Medical stock in a transaction on Monday, May 11th. The stock was acquired at an average cost of $15.00 per share, for a total transaction of $7,999,995.00. Following the completion of the acquisition, the insider owned 2,006,716 shares of the company’s stock, valued at $30,100,740. This trade represents a 36.20% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Dana G. Jr. Mead purchased 7,000 shares of Mobia Medical stock in a transaction on Monday, May 11th. The stock was bought at an average price of $15.00 per share, with a total value of $105,000.00. Following the completion of the acquisition, the director directly owned 7,000 shares of the company’s stock, valued at approximately $105,000. This trade represents a ? increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 1,273,332 shares of company stock worth $19,088,930 over the last ninety days.
Read More
- Five stocks we like better than Mobia Medical
- Appleās Earnings Setup Puts Its Record Rally and AI Patience to the Test
- Oil Prices Are Surging and These 4 Stocks Are Cashing In
- Innovative ETF Strategies That Are Paying Off This Summer
- Forget Tesla: These 2 Earnings Reports Reveal Where the Auto Market Is Heading
Receive News & Ratings for Mobia Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mobia Medical and related companies with MarketBeat.com's FREE daily email newsletter.
